Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation

Resuscitation

Volumn 80, Issue 9, 2009, Pages 994-999

  Turedi, Suleyman ^a   Gunduz, Abdulkadir ^a   Mentese, Ahmet ^a   Dasdibi, Bengu ^a   Karahan, Suleyman Caner ^a   Sahin, Aynur ^a   Tuten, Gamze ^a   Kopuz, Muge ^a   Alver, Ahmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Ischemia; Ischemia modified albumin; Oxidative stress

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; MALONALDEHYDE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLASGOW OUTCOME SCALE; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; PROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS;

EID: 68349121586     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2009.06.007     Document Type: Article

References (27)

1. Prohl J., Röther J., Kluge S., et al. Prediction of short-term and long-term outcomes after cardiac arrest: a prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med 35 (2007) 1230-1237
2. Saklayen M., Liss H., and Markert R. In-hospital cardiopulmonary resuscitation. Survival in one hospital and literature review. Medicine 74 (1995) 163-175
3. Mussack T., Biberthaler P., Gippner-Steppert C., et al. Early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated severe head trauma: a comparative pilot study on common pathomechanisms. Resuscitation 49 (2001) 193-199
4. Pfeifer R., Börner A., Krack A., Sigusch H.H., Surber R., and Figulla H.R. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation 65 (2005) 49-55
5. Tiainen M., Roine R.O., Pettilä V., and Takkunen O. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 34 (2003) 2881-2886
6. Auer J., Berent R., Weber T., et al. Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. CJEM 8 (2006) 13-18
7. Baltacioǧlu E., Akalin F.A., Alver A., Balaban F., Unsal M., and Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post-menopausal women with chronic periodontitis. J Clin Periodontol 33 (2006) 385-392
8. Sulaj M, Saniova B, Drobna E, Schudichova J. Serum neuron specific enolase and malondialdehyde in patients after out-of-hospital cardiac arrest. Cell Mol Neurobiol. Feb 25, 2009. [Epub ahead of print].
9. Anderson T., and Vanden Hoek T.L. Preconditioning and the oxidants of sudden death. Curr Opin Crit Care 9 (2003) 194-198
10. Katz L.M., Young A.S., Frank J.E., Wang Y., and Park K. Regulated hypothermia reduces brain oxidative stress after hypoxic-ischemia. Brain Res 1017 (2004) 85-91
11. Gunduz A., Turedi S., Mentese A., et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 26 (2008) 874-878
12. Meric E, Gunduz A, Turedi S, Cakir E, Yandi M. The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med. May 20, 2008. [Epub ahead of print].
13. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19 (2000) 311-315
14. Yagi K. Lipid peroxides and related radicals in clinical medicine. Adv Exp Med Biol 366 (1994) 1-15
15. Ekmektzoglou K.A., Xanthos T., and Papadimitriou L. Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation 75 (2007) 219-228
16. Almaraz A.C., Bobrow B.J., Wingerchuk D.M., Wellik K.E., and Demaerschalk B.M. Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topic. Neurologist 15 (2009) 44-48
17. Meynaar I.A., Oudemans-van Straaten H.M., van der Wetering J., et al. Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 29 (2003) 189-195
18. Jacobs P., and Noseworthy T.W. National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 18 (1990) 1282-1286
19. Wijdicks E.F., Hijdra A., Young G.B., Bassetti C.L., Wiebe S., and Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 67 (2006) 203-210
20. Fogel W., Krieger D., Veith M., et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 25 (1997) 1133-1138
21. Beg M., Ahmad S., Gandhi S., Akhtar N., and Ahmad Z. A study of serum malondialdehyde in patients of cerebrovascular accident. JIACM 6 (2005) 229-231
22. Montagnana M., Lippi G., Tessitore N., et al. Effect of hemodialysis on traditional and innovative cardiac markers. J Clin Lab Anal 22 (2008) 59-65
23. Borderie D., Allanore Y., Meune C., Devaux J.Y., Ekindjian O.G., and Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50 (2004) 2190-2193
24. Turedi S., Gunduz A., Mentese A., et al. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25 (2007) 770-773
25. Abboud H., Labreuche J., Meseguer E., et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 23 (2007) 216-220
26. Turedi S., Gunduz A., Mentese A., et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 9 (2008) 49
27. Gunduz A., Turedi S., Mentese A., et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 26 (2008) 202-205